Activists Expand Effort To Expose Moderna’s Vaccine Patents – Law360
Activists Expand Effort To Expose Moderna’s Vaccine Patents Law360
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Commentary: Race for a COVID-19 vaccine patent could hurt the public – San Antonio Express-News
Commentary: Race for a COVID-19 vaccine patent could hurt the public San Antonio Express-News
-
In: PATENT NEWS
Covered Business Method Review: Patent Troll Shield – The National Law Review
Covered Business Method Review: Patent Troll Shield The National Law Review
-
In: PATENT NEWS
St. Louis County firm patents treatment for dreaded citrus disease – STLtoday.com
St. Louis County firm patents treatment for dreaded citrus disease STLtoday.com
-
In: PATENT NEWS
Tigo withdraws patent infringement claims against APsystems’ parent company, but case still moving forward – Solar Power World
Tigo withdraws patent infringement claims against APsystems’ parent company, but case still moving forward Solar Power World
-
In: PATENT NEWS
Onxeo Receives Notice of Allowance from USPTO for New Patent Strengthening Protection of AsiDNA™ via Systemic Administration in the United States – StreetInsider.com
Onxeo Receives Notice of Allowance from USPTO for New Patent Strengthening Protection of AsiDNA™ via Systemic Administration in the United States StreetInsider.com
-
In: PATENT NEWS
TikTok’s Latest Challenge Lies in a Patent-Friendly Texas Court – Bloomberg
TikTok’s Latest Challenge Lies in a Patent-Friendly Texas Court Bloomberg
-
In: PATENT NEWS
EGEB: These companies lead in green patent applications – Electrek.co
EGEB: These companies lead in green patent applications Electrek.co
-
In: PATENT NEWS
INmune Bio, Inc. Announces Issuance of Patent from US Patent & Trademark Office Covering INKmune™ Therapy – BioSpace
INmune Bio, Inc. Announces Issuance of Patent from US Patent & Trademark Office Covering INKmune™ Therapy BioSpace
-
In: PATENT NEWS
It’s confirmed: Amarin loses Vascepa patent appeal, putting generics defense on life support – FiercePharma
It’s confirmed: Amarin loses Vascepa patent appeal, putting generics defense on life support FiercePharma